← Back

Amazia, Inc.

Amazia,inc. plans, develops, and operates manga applications internationally. The company offers Manga BANG!, a service that responds to reading methods according to the usage of users and has new works, masterpieces, and works of various genres, including romance novels and comic book adaptations; Manga Tote, a manga app for women; and Manga BANG Comics, an original manga production label. It also operates Tokyo Anime News, an English-language news site related to anime and manga for international audiences. In addition, the company provides Manga Flip, an international manga app. Amazia,inc. was incorporated in 2009 and is headquartered in Tokyo, Japan.

Price · split & dividend adjusted
News & notes moving 4424.JP
4424.JP

Amazia rises for third straight day on approval of investee Skyfall's Tokyo Stock Exchange Growth listing

Amazia rose for a third consecutive day in a weak market. On August 17, the company announced that the new listing of its investee Skyfall on the Tokyo Stock Exchange Growth Market had been approved, and that it would participate in the sale of part of its holdings in Skyfall. This continued to attract market interest.
gamebiz·8dRead more ▾
Artificial Intelligence

TrueData surges on emerging market, Amazia briefly hits limit up

On the emerging market, TrueData surged and briefly hit its daily limit up, while Amazia also briefly hit limit up. TrueData announced that Tsuruha Holdings has decided to adopt its AI service SalesSensor, aiming to improve the accuracy of investment decisions by introducing it by the fiscal year ending February 2027. Amazia announced that its investee Skyfall has received approval for a new listing on the Tokyo Stock Exchange Growth Market, with the listing date scheduled for September 17, 2026. Digital Grid announced that the Maniwa Solar Power Plant built by Vena Energy began commercial operation on the 15th, with annual power generation expected to be approximately 85 million kilowatt-hours. ROXX announced the launch of an FDE service specializing in human resources and recruitment, but the stock price reaction was limited. Heartseed applied to the Tokyo Metropolitan Government for a license to manufacture and sell regenerative medicine products, and the stock rose sharply for a second day. DWTI continued to rise after its glaucoma treatment H-1337 received a patent decision in Canada.
フィスコ·9dRead more ▾